EP 1429801 A1 20040623 - NEUROPILIN AS A NOVEL THERAPEUTIC TARGET FOR MODULATION OF IMMUNE REPONSES
Title (en)
NEUROPILIN AS A NOVEL THERAPEUTIC TARGET FOR MODULATION OF IMMUNE REPONSES
Title (de)
NEUROPILIN ALS NEUER THERAPEUTISCHEN ZIELPUNKT ZUR MODULATION VON IMMUNANTWORTEN
Title (fr)
NEUROPILINE COMME NOUVELLE CIBLE THERAPEUTIQUE POUR LA MODULATION DE REPONSES IMMUNITAIRES
Publication
Application
Priority
- EP 02779818 A 20020926
- EP 01402474 A 20010926
- IB 0204596 W 20020926
Abstract (en)
[origin: WO03035100A1] The invention relates to methods that enable the identification of modulators of immune responses mediated by immune effective cells, especially of the initiation of primary immune responses, and to methods for treating and / or preventing diseases or pathologic conditions associated with or controlled by said immunes responses. More specifically, it concerns methods for identifying compounds that modulate the selective interaction between cells implicated in the immune responses and/or that induce or inhibit the recruitment of semaphorin by neuropilin receptor and that are useful for modulating the immune responses mediated by immune effective cells.
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61P 31/00 (2006.01); A61P 31/18 (2006.01); A61P 37/02 (2006.01)
CPC (source: EP)
A61K 38/17 (2013.01); A61P 31/00 (2017.12); A61P 31/18 (2017.12); A61P 37/02 (2017.12); A61K 2039/505 (2013.01)
Citation (search report)
See references of WO 03035100A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
DOCDB simple family (application)
IB 0204596 W 20020926; EP 02779818 A 20020926